| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004071407A3 Antisense modulation of ptp1b expression |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | WO2003084470A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 01/12/2006 | US20060009630 Composition for treating squamous cell carcinoma comprising an antibody that specifically binds a migration facilitating protein comprising a laminin 5 alpha 3 G4 and/or 5 domain or subdomain thereof, and a pharmaceutically acceptable carrier; treatment of skin cancer |
| 01/12/2006 | US20060009412 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 01/12/2006 | US20060009411 Targeting compounds to a cell nucleus |
| 01/12/2006 | US20060009410 Effects of apolipoprotein B inhibition on gene expression profiles in animals |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009408 siRNA-Mediated gene silencing with viral vectors |
| 01/12/2006 | US20060009407 Administering arginine, lysine; cardiovascular disorder therapy |
| 01/12/2006 | US20060009406 Vectors having both isoforms of beta-hexosaminidase |
| 01/12/2006 | US20060009405 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |
| 01/12/2006 | US20060009404 Tumor ablation in combination with pharmaceutical compositions |
| 01/12/2006 | US20060009403 Dna demethylase antisense and chemotherapy combination |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009388 Treatment of conditions involving demyelination |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060008910 stable nucleic acid-lipid particles (SNALP) |
| 01/12/2006 | US20060008907 Control of gene expression via light activated RNA interference |
| 01/12/2006 | US20060008892 Methods of and pharmaceutical compositions for improving implantation of embryos |
| 01/12/2006 | US20060008884 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 01/12/2006 | US20060008819 Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, FBH58295FL, 57255, and 57255alt molecules and uses therefor |
| 01/12/2006 | US20060008804 Marker genes |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | US20060008463 Tumor antigen peptides derived from cyclophilin B |
| 01/12/2006 | US20060008462 Treatment of mammalian reaction of ige interactions |
| 01/12/2006 | US20060008452 Mesenchymal precursor cell |
| 01/12/2006 | US20060008451 In vivo methods for effecting tissue specific differentiation of embryonic stem cells |
| 01/12/2006 | US20060008450 Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
| 01/12/2006 | US20060008449 Device and methods for treatment of necrotic tissue using stem cells |
| 01/12/2006 | US20060008448 Inhibition of li expression in mammalian cells |
| 01/12/2006 | US20060008446 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques |
| 01/12/2006 | CA2572439A1 Immunostimulatory sirna molecules and uses therefor |
| 01/12/2006 | CA2572129A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | CA2572098A1 B7-dc binding antibody |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/11/2006 | EP1614751A1 Oligoribonucleotide sequence homologous to a cdna region which codes for the human cd40 receptor and duplex oligoribonucleotides, vectors, pharmaceutical compositions and uses associated thereto |
| 01/11/2006 | EP1614423A2 Attenuated pestiviruses |
| 01/11/2006 | EP1613757A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/11/2006 | EP1613649A2 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders |
| 01/11/2006 | EP1613348A2 Methods for modulating angiogenesis with apelin compositions |
| 01/11/2006 | EP1613267A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 01/11/2006 | EP1372723B1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720066A Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 01/11/2006 | CN1720045A Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 01/11/2006 | CN1718245A Nucleic acid vaccine, and its application |
| 01/11/2006 | CN1718242A Recombination vaccine of dog-2 type adenovirus for lyssic virus gluco-/nucleo-structured protein |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984522 Isolation and use of solid tumor stem cells |
| 01/10/2006 | US6984513 Anaerobe targeted enzyme-mediated prodrug therapy |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984487 Cystic fibrosis gene |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | US6984380 Therapeutic treatment or preventing autoimmune diseases, diabetes; removing cells from individual, transfecting the removed cells with DNA encoding normal major histocompatibility complex, reinfusing the transfected cells into body |
| 01/10/2006 | US6984379 Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2081043C Antitumor vaccines comprising il-6 transfected cells |
| 01/06/2006 | CA2471063A1 Novel tfiih subunit |
| 01/05/2006 | WO2006002420A1 Cell-based therapies for ischemia |
| 01/05/2006 | WO2006002394A2 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 01/05/2006 | WO2006002038A2 Immunostimulatory oligonucleotide multimers |
| 01/05/2006 | WO2006001982A2 Methods and compositions for treating neuropathies |
| 01/05/2006 | WO2006001810A2 Improved inhibitor nucleic acids |
| 01/05/2006 | WO2006000719A2 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 01/05/2006 | WO2005103237A9 Method of constructing recombinant herpes simplex virus |
| 01/05/2006 | WO2005077126A3 Use of PPARgamma specific inhibitors as anti-cancer therapeutics |
| 01/05/2006 | WO2005037211A3 Methods and compositions for the treatment of neurological disease |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2004025267A3 Method for testing drug susceptibility of hiv |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | WO2003031598A3 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060003962 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 01/05/2006 | US20060003961 Negative regulation of hypoxia inducible factor 1 by OS-9 |
| 01/05/2006 | US20060003960 Tumor treatment |
| 01/05/2006 | US20060003959 Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same |
| 01/05/2006 | US20060003958 Novel polynucleotides related to oligonucleotide arrays to monitor gene expression |
| 01/05/2006 | US20060003957 RNA virus expression and replication, methods and uses therefor |
| 01/05/2006 | US20060003956 Materials and methods for the derepression of the E-cadherin promoter |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003953 Compositions and their uses directed to bone growth modulators |
| 01/05/2006 | US20060003952 Oligomeric compounds having modified phosphate groups |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |